Fig. 7From: The time-course of protection of the RTS,S vaccine against malaria infections and clinical diseasePredicted cumulative vaccine efficacy against clinical disease over time (in years post dose 3) over all trial sites for the a 5–17 months cohort and b 6–12 weeks cohort with and without booster. The solid lines show the predicted efficacy with the booster schedule and the dashed lines the predicted efficacy with the non-booster scheduleBack to article page